Ask the expert: Triple-negative breast cancer with Elaine Walsh, MB BCh BAO, PhD

general_content

Event details

Making up 15 to 20 percent of all breast cancer diagnoses, triple-negative breast cancer (TNBC) is often seen as a more aggressive subtype that disproportionally affects young, Black, and Latinx communities.

Oncologist Elaine Walsh, MB BCh BAO, PhD answers questions about TNBC symptoms, side-effects, and treatment options for early stage and metastatic breast cancer.

video

audio_embed

speakers_feature

About our expert

Elaine Walsh, MB BCh BAO, PhD

Elaine Walsh, MB BCh BAO, PhD, is a medical oncologist who specializes in the treatment of people with breast cancer. At Memorial Sloan Kettering Cancer Center, Dr. Walsh works as part of a multidisciplinary team to provide the highest level of care and best treatment options to people with breast cancer, while taking individual preferences and priorities into account.

3 Tier Sponsors

Event sponsors

upcoming_events

Upcoming Events

Ask the expert: Updates from the 2023 San Antonio Breast Cancer Symposium (SABCS)

Tue, Dec 12, 2023

Learn More

Thriving Together: 2024 Conference on Metastatic Breast Cancer

Fri, Apr 19, 2024

Learn More

View All Events View Past Events

related_resources_article_carousel

While some breast cancers express hormone receptors or have too many copies of the HER2 gene, other breast cancers may not have these characteristics. Triple-negative breast cancers (TNBC) do not express estrogen receptors, progesterone receptors, or HER2 receptors. About 10% to 15% of breast cancers are triple-negative.

| 13 Min. Read | 7

Follow-up care for TNBC

04/18/18 | BY: Lisa Carey

Learn what follow-up care may be needed and what it entails following a treatment for triple-negative breast cancer.

| 4 Min. Read | 7

Dealing with negative comments

04/18/18 | BY: Lisa Carey

Get tips on how to manage people who have opinions about your breast cancer treatment.

| 6 Min. Read | 2